Key Events This Week
21 Sep: MarketsMOJO upgrades Epigral Ltd to Hold rating
22 Sep: Technical momentum shifts to mildly bullish amid mixed indicators
25 Sep: Technical momentum shifts again, signalling sideways trend
Weekly Close: Stock ends at Rs.1,060.25, down 4.14%
21 September 2026: MarketsMOJO Upgrades Epigral to Hold
On Monday, Epigral Ltd’s stock opened the week at Rs.1,106.00 and closed slightly higher at Rs.1,110.20, a modest gain of 0.38%. This price stability coincided with MarketsMOJO’s upgrade of the company’s rating from Sell to Hold. The upgrade was driven by a reassessment of the company’s operational efficiency, highlighted by a robust ROCE of 21.93% and a low Debt to EBITDA ratio of 1.01, signalling strong management and financial discipline.
Despite these positives, the company’s operating profit has declined at an annualised rate of -5.48% over five years, and recent profit after tax contracted by 27.02% to Rs.180.69 crores. These factors tempered enthusiasm, reflected in the flat financial performance and subdued stock returns over the past year. The upgrade to Hold thus reflects a balanced view recognising operational strengths but acknowledging ongoing challenges.
22 September 2026: Technical Momentum Shifts to Mildly Bullish
Tuesday saw the stock retreat to Rs.1,100.50, down 0.87% on the day, amid a broader market decline where the Sensex fell 0.32%. This price movement followed technical updates indicating a shift from a sideways trend to a mildly bullish stance. Key indicators such as the weekly MACD and Know Sure Thing (KST) turned positive, while daily moving averages also showed mild bullishness, suggesting improving short-term momentum.
However, longer-term indicators remained mixed, with monthly MACD and KST bearish and Bollinger Bands signalling mild to strong bearishness. The Relative Strength Index (RSI) hovered in neutral territory, indicating no clear overbought or oversold conditions. This technical divergence suggested cautious optimism but also highlighted the need for confirmation of a sustained uptrend.
Our latest monthly pick, this Large Cap from Aluminium & Aluminium Products, is outperforming the market! See the analysis that helped our Investment Committee select this winner.
- - Market-beating performance
- - Committee-backed winner
- - Aluminium & Aluminium Products standout
23 September 2026: Continued Price Decline Amid Mixed Market Signals
On Wednesday, Epigral’s stock price declined further to Rs.1,095.70, down 0.44%, while the Sensex gained 0.56%. The stock’s volume increased to 2,296 shares, reflecting heightened trading activity. The technical momentum remained cautiously optimistic on shorter timeframes, but the stock struggled to gain traction amid broader market volatility and sector-specific pressures.
The divergence between weekly bullish and monthly bearish indicators persisted, with the stock trading well below its 52-week high of Rs.1,767.05. This gap underscored the challenges Epigral faces in regaining investor confidence and breaking out of its prolonged downtrend.
24 September 2026: Sharp Drop on Heavy Selling Pressure
Thursday marked the steepest decline of the week, with Epigral’s stock plunging 2.18% to close at Rs.1,071.85. This drop occurred alongside a significant Sensex fall of 1.62%, reflecting a broadly negative market environment. The stock’s volume remained elevated at 2,171 shares, suggesting sustained selling pressure.
Technical indicators began signalling increased volatility and bearishness. Bollinger Bands on weekly and monthly charts showed a bearish stance, while the Know Sure Thing (KST) indicator turned mildly bearish on the weekly timeframe. The Relative Strength Index (RSI) remained neutral, indicating no immediate oversold condition but limited upside momentum.
25 September 2026: Technical Momentum Shifts to Sideways Trend
Friday closed the week with Epigral’s stock falling another 1.08% to Rs.1,060.25. The intraday range between Rs.1,067.05 and Rs.1,097.75 reflected ongoing volatility. The Sensex gained 0.18% on the day, highlighting the stock’s relative weakness.
Technical momentum shifted from mildly bullish to sideways, indicating market indecision. Weekly MACD remained mildly bullish, but monthly MACD and KST were bearish. The On-Balance Volume (OBV) was mildly bearish weekly but bullish monthly, suggesting longer-term accumulation despite short-term selling pressure.
Moving averages stayed mildly bullish on the daily scale, but the overall technical picture was mixed. Dow Theory assessments showed a mildly bearish weekly trend and a mildly bullish monthly trend, reinforcing the sideways consolidation phase. This indecision reflects uncertainty amid sector headwinds and broader market volatility.
Epigral Ltd or something better? Our SwitchER feature analyzes this small-cap stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Daily Price Comparison: Epigral Ltd vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-09-21 | Rs.1,110.20 | +0.38% | 35,787.64 | +0.46% |
| 2026-09-22 | Rs.1,100.50 | -0.87% | 35,672.04 | -0.32% |
| 2026-09-23 | Rs.1,095.70 | -0.44% | 35,870.78 | +0.56% |
| 2026-09-24 | Rs.1,071.85 | -2.18% | 35,291.38 | -1.62% |
| 2026-09-25 | Rs.1,060.25 | -1.08% | 35,353.29 | +0.18% |
Key Takeaways from the Week
Operational Strengths Amid Profit Challenges: Epigral’s strong ROCE of 21.93% and low leverage underpin its operational efficiency, yet the persistent decline in operating profit and a 27.02% contraction in PAT highlight ongoing profitability pressures.
Technical Momentum Mixed and Shifting: The week saw a shift from sideways to mildly bullish momentum early on, supported by weekly MACD and KST indicators, but ended with a sideways trend reflecting market indecision and bearish monthly signals.
Stock Underperformance vs Sensex: Epigral’s 4.14% weekly decline significantly outpaced the Sensex’s 0.76% fall, indicating relative weakness amid broader market volatility and sector-specific headwinds.
Rating Upgrade Reflects Balanced View: The MarketsMOJO upgrade to Hold recognises the company’s strengths and valuation appeal but also signals caution due to flat recent results and mixed technical outlook.
Conclusion: A Week of Mixed Signals and Consolidation
Epigral Ltd’s week was characterised by a notable rating upgrade and fluctuating technical momentum, yet the stock price declined sharply, underperforming the broader market. Operational metrics remain solid, but profit contraction and subdued financial trends weigh on sentiment. The technical landscape is complex, with short-term bullish cues offset by longer-term bearish indicators and a final shift to sideways momentum.
Investors should monitor key support levels near Rs.1,060 and Rs.806, alongside resistance around Rs.1,110 and the 52-week high of Rs.1,767. The Hold rating and mixed technical signals suggest a period of consolidation, with limited near-term directional conviction. Fundamental developments and sector dynamics will be critical in shaping Epigral’s trajectory going forward.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
